171 related articles for article (PubMed ID: 22289490)
1. Array-based cytogenetic approaches in acute myeloid leukemia: clinical impact and biological insights.
Bullinger L; Fröhling S
Semin Oncol; 2012 Feb; 39(1):37-46. PubMed ID: 22289490
[TBL] [Abstract][Full Text] [Related]
2. Genetic classification of acute myeloid leukemia (AML).
Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C
Ann Hematol; 2004; 83 Suppl 1():S97-100. PubMed ID: 15124693
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling in acute myeloid leukemia.
Bullinger L; Valk PJ
J Clin Oncol; 2005 Sep; 23(26):6296-305. PubMed ID: 16155012
[TBL] [Abstract][Full Text] [Related]
4. Delineation of yet unknown cryptic subtelomere aberrations in 50% of acute myeloid leukemia with normal GTG-banding karyotype.
Gross M; Mkrtchyan H; Glaser M; Fricke HJ; Höffken K; Heller A; Weise A; Liehr T
Int J Oncol; 2009 Feb; 34(2):417-23. PubMed ID: 19148476
[TBL] [Abstract][Full Text] [Related]
5. Genes predictive of outcome and novel molecular classification schemes in adult acute myeloid leukemia.
Verhaak RG; Valk PJ
Cancer Treat Res; 2010; 145():67-83. PubMed ID: 20306246
[TBL] [Abstract][Full Text] [Related]
6. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
[TBL] [Abstract][Full Text] [Related]
7. Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approach.
Mandelli F; Petti MC; Lo Coco F
Haematologica; 1998 Nov; 83(11):1015-23. PubMed ID: 9864924
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics.
Ghanem H; Tank N; Tabbara IA
Am J Hematol; 2012 Jan; 87(1):69-77. PubMed ID: 22072438
[TBL] [Abstract][Full Text] [Related]
9. Has gene expression profiling improved diagnosis, classification, and outcome prediction in AML?
Willman CL
Best Pract Res Clin Haematol; 2008 Mar; 21(1):21-8. PubMed ID: 18342809
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications.
Marcucci G; Haferlach T; Döhner H
J Clin Oncol; 2011 Feb; 29(5):475-86. PubMed ID: 21220609
[TBL] [Abstract][Full Text] [Related]
11. Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapse.
Wang ES; Sait SN; Gold D; Mashtare T; Starostik P; Ford LA; Wetzler M; Nowak NJ; Deeb G
Cancer Genet Cytogenet; 2010 Oct; 202(2):101-7. PubMed ID: 20875872
[TBL] [Abstract][Full Text] [Related]
12. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic abnormalities in adult non-promyelocytic acute myeloid leukemia: a concise review.
Marchesi F; Annibali O; Cerchiara E; Tirindelli MC; Avvisati G
Crit Rev Oncol Hematol; 2011 Dec; 80(3):331-46. PubMed ID: 21123080
[TBL] [Abstract][Full Text] [Related]
14. Array comparative genomic hybridization analysis of adult acute leukemia patients.
Yasar D; Karadogan I; Alanoglu G; Akkaya B; Luleci G; Salim O; Timuragaoglu A; Toruner GA; Berker-Karauzum S
Cancer Genet Cytogenet; 2010 Mar; 197(2):122-9. PubMed ID: 20193845
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and cytogenetics studies on acute myeloid leukemia with abnormality of chromosome 11].
Lu Y; Xu W; Chen Z; Lou J; Jin J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):583-5. PubMed ID: 18841578
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of the most common chromosome translocations in adult acute myeloid leukemia.
Mrózek K; Bloomfield CD
J Natl Cancer Inst Monogr; 2008; (39):52-7. PubMed ID: 18648004
[TBL] [Abstract][Full Text] [Related]
18. Array CGH in human leukemia: from somatics to genetics.
van der Veken LT; Buijs A
Cytogenet Genome Res; 2011; 135(3-4):260-70. PubMed ID: 21893961
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetics in acute leukemia.
Mrózek K; Heerema NA; Bloomfield CD
Blood Rev; 2004 Jun; 18(2):115-36. PubMed ID: 15010150
[TBL] [Abstract][Full Text] [Related]
20. cDNA microarray analysis of non-selected cases of acute myeloid leukemia demonstrates distinct clustering independent of cytogenetic aberrations and consistent with morphological signs of differentiation.
Øyan AM; Bø TH; Jonassen I; Gjertsen BT; Bruserud Ø; Kalland KH
Int J Oncol; 2006 May; 28(5):1065-80. PubMed ID: 16596222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]